GC-MS analysis of Menstrosap- An ayurvedic patent product for dysmenorrhea
DOI:
https://doi.org/10.70066/jahm.v11i5.852Abstract
Primary dysmenorrhea is a lower abdominal pain occurring during the menstrual cycle which is not associated with other diseases or pathology. It hinders the day-to-day activities of women. Treatment of primary dysmenorrhea aims to relieve pain and other symptoms. Menstrosap is an Ayurvedic proprietary medicine manufactured by Sitaram Ayurveda Private Ltd. Thrissur for dysmenorrhea. The medicine is a combination of Sapthasaram Kahayam (decoction), Hinguvachadi Choornam (powder), Sesame oil and Ricinus oil. To explain the efficacy and mechanism of action, clinical trials and knowledge of bio-medical compounds in the product are mandatory. This type of study is the need of the hour for better scientific validation. To explain the mode of action of the product scientifically, Gas Chromatographic- Mass Spectrometric analysis was done. GC-MS revealed nine compounds that explain scientifically the mode of action of the drug. Among the nine compounds identified, six compounds show anti-inflammatory activity. Menstrosap also shows the presence of omega-7 fatty acids which also helps to reduce the symptoms of dysmenorrhea.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Meenu Madhavan
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.
